Industry3h ago
Isomorphic Labs Raises $2.1 Billion For Drug Design
A $2.1 billion funding round fuels Isomorphic Labs as it scales its Drug Design Engine. The DeepMind spinoff partnered with Novartis and Eli Lilly to identify hidden drug targets. This technical pivot targets the high failure rate of AI-designed medicines by integrating protein structure prediction into the early discovery pipeline.